About the Journal


Journal History

The Brazilian Journal of Pharmaceutical Sciences has its origin in the "Anais de Farmácia e Odontologia da USP", which began in 1939. In 1963, volume 1 of "Revista da Faculdade de Farmácia e Bioquímica da Universidade de São Paulo" was published and in 1970, it was changed to "Revista de Farmácia e Bioquímica da Universidade de São Paulo". In 1999, it was totally remodeled and named as Revista Brasileira de Ciências Farmacêuticas/Brazilian Journal of Pharmaceutical Sciences. From 2009 on, after 10 years of its first editorial reformulation and celebrating 70 years of publishing, a new phase has started, and the publication is now  Brazilian Journal of Pharmaceutical Sciences, accepting papers only in English. This decision has the main purpose of widening its visibility outside the country, towards consolidating  its role as the main publication in the Pharmaceutical Sciences area in Brazil.



The Brazilian Journal of Pharmaceutical Sciences (BJPS) is a peer-reviewed electronic journal
published continually by the School of Pharmaceutical Sciences of the University of São Paulo. The
purpose of the Brazilian Journal of Pharmaceutical Sciences is to publish manuscripts that significantly
contribute to knowledge in all areas of Pharmaceutical Sciences, including:
1. Medicinal Chemistry & Pharmacognosy
2. Pharmaceutical Technology, Drug development, Pharmaceutics & Biopharmaceutics, Drug
3. Clinical Pharmacy and Pharmacokinetics, Pharmaceutical Care, Pharmaceutical Services.
4. Clinical-Bioanalytical Chemistry and Pharmaceutical Analysis
5. Food Science and Nutrition, including Food Analysis and Technology, Nutrigenomics,
Immunonutrition, Functional foods and supplements, Food bioactive compounds, the interaction
between drugs and foods
6. Vaccines and Biologicals
7. Cosmetology
8. Toxicology
Journal's policy, which are used as guidelines for the review of manuscripts:
1. Out of scope
The paper must report on recent advances in pharmaceutical technology, biopharmaceutics,
pharmaceutical biotechnology, medication use, and pharmacist services of major importance.
Immediate rejection criteria:
a. Description of analytical methods with no relation to pharmaceutics, biopharmaceutics, or
pharmaceutical biotechnology.
b. Mere description of compound synthesis, processes, validation, etc. without any pharmaceutical
c. Inappropriate promotion of a trademark or a product.
d. Regulatory issues with no relation to pharmaceutics, biopharmaceutics, or pharmaceutical
2. Too preliminary
A paper must be based on a thorough and extensive study, using established or well-described
methods and including proper controls. Research must be hypothesis-driven and conclusions must be
supported by the data presented.
Immediate rejection criteria:
a. No proof of concept in either an in vivo or an in vitro evaluation.
b. No clear indication of the use of the product or formulation.
c. No clear description of the materials & methods used in the pharmaceutical field.
d. Use of inadequate or insufficient methods.
e. Inappropriate statistical analysis.
f. Lack of proper controls.
g. Lack of coherent discussion of the results.
3. Lack of novelty:
The study described in the manuscript must represent a novel approach

Immediate rejection criteria
a. Repetition of previously published data, either partially or entirely.
b. Simple variation of parameters of a formulation, processes, synthesis, etc.
c. Modification of well-known delivery systems with no novelty and/or benefit.
d. Plagiarism (intentional and unacknowledged copying of other’s work) and self-plagiarism (re-use
of parts of an author’s previously published work without proper attribution). Each author will be
responsible to present the plagiarism certificate using software tools to screen the submitted
manuscripts for check text overlap.
The following papers will not be accepted for publication:
a. Studies on human subjects not approved by an accredited Ethics Committee or without written
informed consent from the subject or legal guardian.
b. Studies on animals not approved by an accredited Ethics and Animal Care Committee.
c. Manuscripts describing plant extract activity that do not Identify quali and quantitative chemical
markers of the extract.

Editorial Process

All manuscripts go through an initial evaluation that considers the presence of all attachments (figures, signed copyright form) and text format. If the manuscript is apt in this stage, then the Editor in Chief evaluates the quality of the content as well as if the scope and basic policies are in accordance. Then the manuscript goes through a single blind peer review. Later on, the Editor in chief decides on acceptance or rejection.

Open Acess Policy

BJPS is non-profit journal, all the articles published are in full open acess for any person.


Article Processing Charge (APC)

We do not have any charges for publication. The journal and it's sponsors cover all costs for publication.


Publication Frequency


Indexing sources

Chemical Abstracts - Coden CHABAB.

• ISI Web of Science – Thompson Reuters.
Website: www.thomsonreuters.com or direct to www.apps.isiknowledge.com

• Literatura Latino-Americana e do Caribe em Ciências da Saúde - Lilacs

• QUALIS/CAPES- Classificação B3 para Farmácia.    Website: www.periodicos.capes.gov.br




The publication receives finnancial support from:

- Faculdade de Ciências Farmacêuticas


Sources of Support